Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Nat Commun ; 15(1): 4862, 2024 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-38862464

RESUMEN

As spaceflight becomes more common with commercial crews, blood-based measures of crew health can guide both astronaut biomedicine and countermeasures. By profiling plasma proteins, metabolites, and extracellular vesicles/particles (EVPs) from the SpaceX Inspiration4 crew, we generated "spaceflight secretome profiles," which showed significant differences in coagulation, oxidative stress, and brain-enriched proteins. While >93% of differentially abundant proteins (DAPs) in vesicles and metabolites recovered within six months, the majority (73%) of plasma DAPs were still perturbed post-flight. Moreover, these proteomic alterations correlated better with peripheral blood mononuclear cells than whole blood, suggesting that immune cells contribute more DAPs than erythrocytes. Finally, to discern possible mechanisms leading to brain-enriched protein detection and blood-brain barrier (BBB) disruption, we examined protein changes in dissected brains of spaceflight mice, which showed increases in PECAM-1, a marker of BBB integrity. These data highlight how even short-duration spaceflight can disrupt human and murine physiology and identify spaceflight biomarkers that can guide countermeasure development.


Asunto(s)
Coagulación Sanguínea , Barrera Hematoencefálica , Encéfalo , Homeostasis , Estrés Oxidativo , Vuelo Espacial , Animales , Humanos , Encéfalo/metabolismo , Barrera Hematoencefálica/metabolismo , Ratones , Coagulación Sanguínea/fisiología , Masculino , Secretoma/metabolismo , Ratones Endogámicos C57BL , Vesículas Extracelulares/metabolismo , Proteómica/métodos , Biomarcadores/metabolismo , Biomarcadores/sangre , Femenino , Adulto , Proteínas Sanguíneas/metabolismo , Persona de Mediana Edad , Leucocitos Mononucleares/metabolismo , Proteoma/metabolismo
2.
J Crohns Colitis ; 16(6): 978-991, 2022 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-34893805

RESUMEN

BACKGROUND AND AIMS: Crohn's disease is a debilitating chronic inflammatory disorder of the mammalian gastrointestinal tract. Current interventions using anti-tumour necrosis factor [anti-TNF] biologics show long-term benefit in only half of patients. This study focused on the role of the TNF receptor 1 [TNFR1] in pathogenesis in a TNF-driven model of ileitis. METHODS: We studied TNFΔAU-rich element [ARE]/+ [TNFdARE] mice, which develop progressive ileitis similar to Crohn's ileitis. Histopathological analysis and gene expression profiling were used to characterize disease progression from 5 to 16 weeks. Mice with TNFR1 hemizygosity [TNFdARE/R1het] allowed us to assess gene dosage effects. Transcriptional profiling established inflection points in disease progression; inflammatory gene expression increased at 8 weeks with a plateau by 10 weeks, so these were selected as endpoints of treatment using the TNF biologic infliximab and the TNFR1-specific XPro1595. Differences in recruitment of cells in the lamina propria were assessed using flow cytometry. RESULTS: TNFdARE/R1het mice displayed stable long-term protection from disease, associated with decreased recruitment of CD11bhiF4/80lo monocytes and CD11bhiLy6Ghi neutrophils, suggesting an important role of TNFR1 signalling in pathogenesis, and indicating potential benefit from TNFR1-specific intervention. Treatment with infliximab and XPro1595 both showed a similar impact on disease in TNFdARE mice. Importantly, these beneficial effects were greatly surpassed by hemizygosity at the TNFR1 locus. CONCLUSIONS: Treatment with either infliximab or XPro1595 produced moderate protection from ileitis in TNFdARE mice. However, hemizygosity at the TNFR1 locus in TNFdARE mice showed far better protection, implicating TNFR1 signalling as a key mediator of TNF-driven disease.


Asunto(s)
Enfermedad de Crohn , Ileítis , Animales , Enfermedad de Crohn/complicaciones , Progresión de la Enfermedad , Ileítis/tratamiento farmacológico , Ileítis/etiología , Ileítis/prevención & control , Infliximab/farmacología , Infliximab/uso terapéutico , Mamíferos/metabolismo , Ratones , Receptores Tipo I de Factores de Necrosis Tumoral/genética , Inhibidores del Factor de Necrosis Tumoral , Factor de Necrosis Tumoral alfa/metabolismo
3.
Sci Total Environ ; 792: 148450, 2021 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-34157526

RESUMEN

In communities surrounding the Salton Sea, high rates of asthma are associated with high aerosol dust levels. However, the Salton Sea itself may play an additional role in pulmonary health. Therefore, to investigate a potential role of the Salton Sea on pulmonary health, we exposed mice to aerosolized Salton Sea water for 7 days and assessed tissue responses, including cellular infiltration and gene expression changes. For reference, mice were also exposed to aerosolized fungal allergen (Alternaria sp.) and Pacific Ocean aerosols. Exposure to aerosolized Alternaria sp. induced dramatic allergic inflammation, including neutrophil and eosinophil recruitment to the bronchoalveolar lavage fluid (BALF) and lung tissue. By contrast, Salton Sea "spray" induced only B cell recruitment to the lung tissue without increased inflammatory cell numbers in BALF. However, there were consistent gene expression changes suggestive of an inflammatory response. The response to the Salton Sea spray was notably distinct from the response to Pacific Ocean water, which induced some B cell recruitment but without an inflammatory gene expression profile. Our studies suggest that soluble components in Salton Sea water promote induction of a unique inflammation-associated response, though any relationship to asthma remains to be explored.


Asunto(s)
Polvo , Pulmón , Aerosoles/toxicidad , Alérgenos , Animales , Líquido del Lavado Bronquioalveolar , Inflamación/inducido químicamente , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA